The expression of late infantile neuronal ceroid lipofuscinosis (CLN2) gene product in human brains

Neuroscience Letters

Volumn 257, Issue 2, 1998, Pages 113-115

  Oka, Akira ^a,b   Kurachi, Yukiko ^a,c   Mizuguchi, Masashi ^d   Hayashi, Masaharu ^e   Takashima, Sachio ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

CLN2; Gene; Human; Immunohistochemistry; Late infantile ceroid lipofuscinosis; Western blotting

Indexed keywords

GENE PRODUCT;

ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ELECTRON MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NEUROLOGIC DISEASE; NEURONAL CEROID LIPOFUSCINOSIS; PRIORITY JOURNAL;

ADOLESCENT; BLOTTING, WESTERN; BRAIN; CADAVER; CYTOPLASM; ENDOPEPTIDASES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEUROGLIA; NEURONS; PEPTIDE HYDROLASES;

EID: 0032573613     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00787-3     Document Type: Article

References (10)

1. Consortium The International Batten Disease Isolation of a novel gene underlying Batten disease, CLN3. Cell. 82:1995;949-957.
2. Friede, R.L., Ceroid-lipofuscinosis and miscellaneous lipidosis. In Developmental Neuropathology, 2nd edn., Springer, Berlin, 1989, pp. 448-460.
3. Goebel H.H. Morphologic diagnosis in neuronal ceroid lipofuscinosis. Neuropediatrics. 28:1997;67-69.
4. Goebel H.H., Sharp J.D. The neuronal ceroid-lipofuscinosis: recent advances. Brain Pathol. 8:1998;151-162.
5. Mitchison H.M., Hofmann S.L., Becerra C.H.R., Munroe P.B., Lake B.D., Crow Y.J., Stephenson J.B.P., Williams R.E., Hofman I.L., Taschner P.E.M., Martin J.-J., Philippart M., Andermann E., Andermann F., Mole S.E., Gardiner R.M., O'Rawe A.M. Mutations in the palmitoyl-protein thioesterase gene (PPT; CLN1) causing juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposits. Hum. Mol. Genet. 7:1998;291-297.
6. Mizuguchi M., Takashima S., Kakita A., Yamada M., Ikeda K. Lissencephaly gene product localization in the central nervous system and loss of immunoreactivity in Miller-Dieker syndrome. Am. J. Pathol. 147:1995;1142-1151.
7. Oka A., Takashima S. Induction of cyclo-oxygenase 2 in brains with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons. NeuroReport. 8:1997;1161-1164.
8. Sleat D.E., Donnelly R.J., Lackland H., Liu C.-G., Sohar I., Pullarkat R.K., Lobel P. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science. 277:1997;1802-1805.
9. Vesa J., Hellsten E., Verkruyse L.A., Camp L.A., Rapola J., Santavuori P., Hofmann S.L., Peltonen L. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature. 376:1995;584-587.
10. Wisniewski K.E., Zhong N., Kaczmarski W., Kaczmarski A., Kida E., Brown W.T., Schwarz K.O., Lazzarini A.M., Rubin A.J., Stenroos E.S., Johnson W.G., Wisniewski T.M. Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis. Ann. Neurol. 43:1998;106-110.